Bortezomib a Safe Treatment for Patients with Multiple Myeloma and Cystic Fibrosis

INTRODUCTION: Bortezomib is a proteasome inhibitor that targets myeloma cell and its bone marrow microenvironment. Intravenous Bortezomib with or without dexamethasone, is effective and well tolerated in patients with relapsed/refractory multiple myeloma (MM). METHODS: We used Bortezomib without cor...

Full description

Saved in:
Bibliographic Details
Main Authors: Gentilini, Fabiana, Levi, Anna, Federico, Vincenzo, Russo, Eleonora, Foà, Robin, Petrucci, Maria Teresa
Format: Artigo
Language:Inglês
Published: Università Cattolica del Sacro Cuore 2012
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3375716/
https://ncbi.nlm.nih.gov/pubmed/22708050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2012.035
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items